Efficacy and Patient Tolerability of Omidenepag Isopropyl in the Treatment of Glaucoma and Ocular Hypertension

Current therapeutic approaches for glaucoma aim to reduce intraocular pressure (IOP), which is the only available and reliable strategy proven to control the risk of disease development and progression. Omidenepag isopropyl (OMDI) is a novel topical ocular hypotensive agent that was launched onto th...

Descripción completa

Detalles Bibliográficos
Autores principales: Matsuo, Masato, Matsuoka, Yotaro, Tanito, Masaki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9058248/
https://www.ncbi.nlm.nih.gov/pubmed/35510270
http://dx.doi.org/10.2147/OPTH.S340386

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9058248/
https://www.ncbi.nlm.nih.gov/pubmed/35510270
http://dx.doi.org/10.2147/OPTH.S340386

Ejemplares similares